Global Plasma Protein Therapeutics Market to Reach USD 51.85 Billion by 2032, Growing at a CAGR of 8.2%”
DefinitionPlasma protein therapeutics are specialized biologics derived from human blood plasma, used to treat various chronic and rare diseases. These therapies include essential proteins such as immunoglobulins, coagulation factors, albumin, and other plasma-derived medicinal products. They play a critical role in managing conditions like hemophilia, primary immunodeficiency disorders, and autoimmune diseases. These therapeutics are manufactured … Read more